Trials / Unknown
UnknownNCT03602742
Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Sigknow Biomedical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label study to investigate the functional features of prolonged monitoring by 14-day EZYPRO® to improve the medical care and/or diagnosis for the patient with arrhythmia. Patients will be enrolled by outpatient basis from two clinical study sites. Enrolled patients will wear a traditional 24-hour Holter monitor and an 14-day EZYPRO® which can provide monitoring data for up to 14 days. This study will allow a direct comparison between two devices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EZYPRO® | Wear two devices including 24-hour Holter and 14-day continuous EZYPRO® to evaluate the performance |
Timeline
- Start date
- 2018-03-16
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2018-07-27
- Last updated
- 2018-07-27
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03602742. Inclusion in this directory is not an endorsement.